Sorafenib induced acral pigmentation: A new entity
Sorafenib is a multikinase inhibitor commonly used for the treatment of advanced renal cell and hepatocellular carcinoma. The commonly reported dermatological adverse effects of Sorafenib include hand-foot syndrome (HFS), alopecia, pruritus, facial and scalp erythema, splinter hemorrhages, keratoaca...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2015
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/fd80886f7a3142ab83d6f4136991577e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|